Breaking News

Recipharm Expands Pharmaceutical Development Capabilities

Invests in oral solid dosage, sterile fill & finish and enhances existing development capabilities.

Recipharm, a CDMO, is expanding its pharmaceutical development capabilities, through investments and the integration of cutting-edge technologies. This investment aims to enhance services for early- and late- stage product development, including clinical study supply at small and pilot scales and wide range of commercial technologies.
 
Following this investment, services will cover the whole life cycle of a molecule from APIs route scouting to commercial manufacturing of pharmaceutical products.

Expanding small molecule development capabilities 

Recipharm’s center of excellence for small molecules (NCEs and generics) in Bengaluru, India, is expanding its capabilities with a new lab for sterile product development. This is in addition to the new Extractables and Leachables, Nitrosamines and Elemental Impurities labs for comprehensive analytical services.
 
In Zwickau, Germany, Recipharm’s pilot-scale development center focuses on dry granulation, tableting and hard capsule filling, with expertise in combination products.
 
In addition, recent investments at both Bengaluru and Zwickau include advanced material characterization equipment, a compression and compaction simulator, a Mini-Pactor for dry granulation, a pilot-scale capsule filler and a small-scale tablet press.

Enhancing sterile product development 

Recipharm has strengthened its preclinical, clinical and pilot scale sterile development capabilities for both small and large molecules, including liquid vials, pre-filled syringes, blow-fill-seal and lyophilized products. Investments include the establishment of a development lab for sterile formulations for small molecules in Bengaluru, the installation of a GMP VarioSys line for vials and pre-filled syringes at the Wasserburg site and a GMP LAB+ equipment at the Kaysersberg site.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters